The AI in Business Podcast

In this engaging discussion, Matt DeLauro, President of SEON Technologies and a fraud prevention expert, dives into the complexities of modern fraud detection. He reveals the limitations of outdated systems and the rise of 'fraud as a service' that empowers businesses to combat threats. Matt emphasizes the necessity of a 'shift left' strategy for early detection and balancing user experience with security. He also highlights innovative tactics for managing chargebacks and the distinct challenges faced by retail versus financial sectors.

Patricio La Rosa, Head of End-to-End Decision Science at Bayer, brings over 20 years of experience in AI and data science. He discusses how AI optimizes drug development, improving trial planning and patient engagement. The conversation highlights the ethical implications of AI, emphasizing the importance of transparency and trust in clinical settings. Patricio also explores barriers to AI adoption and offers strategies for integrating AI into decision-making processes, drawing valuable lessons from agriculture and retail to enhance healthcare outcomes.

Akhil Khunger, VP in Quantitative Analytics at Barclays, shares insights on customer-facing AI in financial services. He discusses the evolving safety measures being integrated into these systems, tackling risks like prompt injection and model jailbreaking. Akhil highlights the balancing act between enhancing user experience and adhering to regulatory requirements. He further explores the challenges of building transparent and trustworthy AI systems, emphasizing the significance of user feedback and robust governance frameworks.

Brice Challamel, Head of AI Products and Innovation at Moderna, shares his insights on the transformative role of AI in life sciences. He discusses how Moderna integrates AI to enhance collaboration and accelerate product development while emphasizing the need for human-centered strategies. Brice explores the balance between AI and human creativity, potential healthcare improvements, and lessons from less regulated sectors. He highlights the importance of education and cultural shifts in adapting to AI’s evolving landscape.

Dimitri Sirota, Co-founder and CEO of BigID, dives into the pressing issues surrounding data security in the age of AI. He highlights the growing challenges of managing unstructured data and the risks of 'shadow AI.' With the surge in cloud adoption and strict global regulations, he emphasizes the importance of understanding 'crown jewel' data for trustworthy AI. Dimitri advocates for zero-trust security models and real-time monitoring to safeguard enterprise data and ensure compliance amidst evolving threats.

Damion Nero, Head of Data Science at Takeda Pharmaceuticals, shares his expertise in applying AI and machine learning to drug development. He discusses how AI is revolutionizing clinical trials by streamlining tasks and enhancing patient engagement. Topics include the transformative potential of decentralized models and the integration of diverse data sources. Damion also highlights the ongoing challenges of trust and data integrity in healthcare, as well as the promise of future advancements in supply chain efficiency.

Marie Flanagan, a Director at IQVIA, dives into the exciting intersection of AI and safety workflows in healthcare. She discusses the surge in data complexity, from social media insights to audio recordings, posing challenges for pharmacovigilance. Marie highlights how AI tools like voice-to-text transcription are revolutionizing data management, allowing safety teams to focus on critical tasks. She stresses the irreplaceable role of human judgment in interpreting nuanced clinical situations, showcasing a balanced approach to enhance patient safety.

Akhil Khunger shares insights on how financial institutions are transforming stress testing and risk modeling with AI. The discussion highlights the benefits of modular and decoupled processes for faster regulatory compliance. AI-driven code generation and user-friendly APIs are enabling precise scenario analyses across complex portfolios. Plus, learn how global teams are utilizing AI to move away from outdated tech stacks, making business planning more efficient and flexible across various jurisdictions.

Raheel Retiwalla, Chief Strategy Officer at Productive Edge, discusses the groundbreaking potential of agentic AI in healthcare. With two decades of experience, he explains how agentic AI differs from traditional models by enabling actionable insights. They explore the integration of AI agents and the necessary governance frameworks for success. Raheel highlights real-world applications that enhance patient outcomes and streamline workflows. He underscores the importance of aligning IT with operational needs to maximize efficiency in healthcare systems.

Shub Agarwal, Senior VP of Product Management for AI at U.S. Bank and USC professor, discusses the transformative role of responsible AI in banking. He emphasizes that method matters more than models, advocating for user-centric designs. Shub highlights the importance of data governance to ensure ethical practices as the industry innovates. He also delves into the significant impacts of AI in sales and fraud detection, showcasing how it's personalizing experiences and balancing technology with human oversight.